Global Human Micobiome Market 2016 by Vedanta, Rebiotix, Enterologics, Metabogen, Symberix, Miomics to 2021

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that’s 2 to 6 pounds of bacteria in a 200-pound adult).

Access Full Report: http://www.fiormarkets.com/report/global-human-micobiome-market-by-manufacturers-regions-type-14486.html

Scope of the Report:
This report focuses on the Human Micobiome in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC

Request For Sample Report: http://www.fiormarkets.com/report-detail/14486/request-sample

Market Segment by Regions
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Other

Market Segment by Applications
Treatment
Diagnosis

There are 13 Chapters to deeply display the global Human Micobiome market report.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com

banner